Osteoarthritis

Osteoarthritis and hypertension: observational and Mendelian randomization analyses

Arthritis Res TherPublished Cross-sectional study and Mendelian randomisation study

Main finding · Hypertension (NHANES, adjusted for multiple confounding factors)Result — go to the resultOdds ratio 1.30 95% CI 0.97–1.73

Authors' conclusion

Our study found that OA patients had a higher risk of hypertension only among males in the observational study. However, MR analysis did not uncover any causal relationship between OA and hypertension.

Study context

Population
Participants in National Health and Nutrition Examination Survey (NHANES) 2013 to 2020NHANES 2013–2020
Participants
24,871 participants
Exposure
Osteoarthritis (OA) vs no OA, for hypertension
Outcome
Association between OA and hypertension
Methodological detailsretrospective, weighted logistic regression, Mendelian randomization, reverse Mendelian randomization (MR)
  • Retrospective
  • Weighted logistic regression
  • Mendelian randomization
  • Reverse MR

Main finding

As reported in the abstract

Hypertension (NHANES, adjusted for multiple confounding factors)

Odds ratio

1.30

95% CI 0.97–1.73

P = 0.089

OAvs No OA
OR 1.30 (95% CI 0.97–1.73); P = 0.089

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Hypertension in males (subgroup, NHANES)2.25 (1.17–4.32)P = 0.019

Hypertension, MR (IVW) by OA phenotype

OR (95% CI)P value
Knee OAIVW1.024 (0.931–1.126)P = 0.626
Hip OAIVW0.990 (0.941–1.042)P = 0.704
Knee or hip OAIVW1.005 (0.915–1.105)P = 0.911
OA from UK BiobankIVW0.796 (0.233–2.714)P = 0.715
Findings consistent across genders and in reverse MR

Original publication

Osteoarthritis and hypertension: observational and Mendelian randomization analyses. Arthritis Res Ther. Published 17 April 2024. doi:10.1186/s13075-024-03321-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.